Skip to Main Content

Hello, everyone, and how are you today? We are doing just fine, even as we adjust to a different time zone. Not surprisingly, this calls for multiple cups of stimulation and, as always, you are invited to join us. Remember, no prescription is required. On that note, time to get cracking. Here are some items of interest. Hope you conquer the world today and, of course, do keep in touch …

CVS is selling Adrenaclick, an authorized generic allergy emergency injector marketed by Impax Laboratories, for a cash price of $109.99. This compares to $339.99 for the authorized generic for EpiPen sold by Mylan Pharmaceuticals. Meanwhile, Cigna will no longer cover EpiPen without prior authorization and, in at least three states, Medicaid recipients must similarly obtain prior approval before buying the device, according to STAT. Cigna, however, will cover the newly launched generic version of EpiPen, which carries a $300 list price, about half of the brand-name version. Mylan decided to sell a generic after uproar over price hikes for original device.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!